AVX-001 T26693
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
AVX-001, a cytosolic phospholipase A2 (cPLA2) inhibitor, is used potentially for the treatment of psoriasis.
CAS nr:
300553-18-8
Purity:
98%
Molecular Weight:
386,51
SMILES:
O=C(CSC/C=C/CC/C=C\C/C=C\C/C=C\C/C=C\CC)C(F)(F)F
Formula:
C21H29F3OS
Pathway:
Target:
